期刊文献+

炭疽AVA疫苗特异性抗体分泌细胞检测方法的建立

Development of a method for detecting AVA-antigen specific antibody secreting cells
下载PDF
导出
摘要 目的 应用酶联免疫斑点(ELISPOT)技术,建立一种检测炭疽AVA免疫后特异性抗体分泌细胞的方法,用于检测和评价炭疽无菌培养滤液抗原特异性抗体形成细胞的功能.方法 无菌分离小鼠脾细胞,建立一系列特异性ELISPOT检测炭疽无菌培养滤液抗原特异性抗体分泌细胞的参数:包括抗原最佳包被浓度、细胞最适孵育时间、反应体系中细胞浓度以及亲和素抗体工作浓度的确定,同时检测上清中抗体效价,并以不相关抗原包被,检验方法的敏感性和特异性.结果 当抗原包被浓度为7.5μg/mL时,不同细胞浓度反应曲线最稳定 细胞数为5×10^6/mL时,不同包被浓度形成的斑点数适量,易于计数 且在抗体稀释度相同情况下,脾细胞孵育时间为3~6 h所获得的斑点数最清晰,背景着色最浅,容易被仪器识别 同时,特异性抗原包被组所获得的斑点频数高于无关抗原包被组(P<0.01) 反应体系上清中未检测到抗原特异性抗体.结论 该方法敏感、特异,可用于AVA抗原免疫后体液免疫评价. Objective To establish a method for detecting AVA-antigen specific antibody-secreting cells (ASCs) with enzyme linked immunospot essay, which can be used to detect and evaluate the function of AVA-antigen specific ASCs, and to observe the humoral immune responses in mice after being inoculated with AVA. Methods The level of Ig and its subtype in sennn was detected. Mice were sacrificed and spleen cells were isolated. A series of parameters for detecting AVA specific ASCs was established: including the optimal concentration of coated antigen, optimal incubation time of spleen cells, and the performance concentration of Biotin-Igs. The sensitivity and specificity of the method was checked by detecting lgG levels in the culture supernatant and coating with irrelevant antigen. Results When antigen concentration was 7.5μg/mL, the reaction curve was the most stable compared with the others. The amount of spots in cell with concentration of 5× 10^6 mL^-1 were in moderate level and easy to be recognized. Besides, the detected spots were the clearest and the background was the lightest when the incubation time was 3 - 6 h comparing with the others under the same circmnstance. Lastly, the amount of spots coated with AVA-antigen was much higher than that coated with irrelevant antigen ( P 〈 0.01 ). Antigen-specific ASC was undetected in the culture supernant. Comclusion The ELISPOT essays represent a sensitive, specific, and reliable tool for tracking humoral immune responses after AVA vaccination.
出处 《免疫学杂志》 CAS CSCD 北大核心 2007年第4期452-455,共4页 Immunological Journal
基金 国家"973"课题(2002CB513208)
关键词 AVA(炭疽无菌培养滤液佐剂吸附苗) ELISPOT(酶联免疫斑点) ASC(抗体分泌细胞) SFC(斑点形成细胞) Anthrax vaccine absorbed Enzyme linked immunospot Antibody secreting cell Spot forming cell
  • 相关文献

参考文献10

  • 1Rogers JV,Casbohm SL,Giannunzio LF.et at.Transcriptional analysis of protective antigen-stimulated PBMC from non-human primates vaccinated with the anthrax vaccine absorbed[J].Vaccine,2006,24(17):3 609-3 617.
  • 2庄汉澜,胡娟,梁厚勤,等.炭疽保护性抗原的制备Ⅱ,深层培养法.军事医学科学院院刊,1979,8(4):473-480.
  • 3董梅,马丽娟,张松乐,张良艳,郭习勤,邢丽,杨海荣,王希良.炭疽杆菌培养上清液抗原的制备及免疫保护效果测定[J].免疫学杂志,2006,22(3):321-324. 被引量:3
  • 4Boyaka PN,Tafaro A,Fischer R,et al.Effective mucosal immunity to anthrax:neutralizing antibodies and Th cell responses following nasal immunization with protective antigen[J].J Immunol,2003,170(11):5 636-5 643.
  • 5Little SF,Ivins BE,Fellows PF,et al.Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine[J].Vaccine,2004,22(3/4):422-430.
  • 6Oxenius A,Zinkernagel RM,Hengartner H.CD4^+ T-cell induction and effector functions:a comparison of immunity against soluble antigens and viral infections[J].Adv Irmnunol,1998,70:313-367.
  • 7Arlen P,Tsang KY,Marshall JL,et al.The use of a rapid ELISPOT assay to analyze peptide-specific immune responses in carcinoma patients to peptide vs.recombinant poxvirus vaccines[J]Cancer Immunol Immunother,2000,49(10):517-529.
  • 8Crotty S,Kersh EN,Cannons J,et al.SAP is required for generating long-term humoral immunity[J].Nature,2003,421(16):282-287.
  • 9Crotty S,Aubert RD,Glidewell J,et al.Tracking human antigen-specific memory B cells:a sensitive and generalized ELISPOT system[J].J Immunol Methods,2004,286(1/2):111-122.
  • 10Crotty S,Feigner P,Davies H,et al.Cutting ease:longterm B cell memory in humans after smallpox vaccination[J].J Imrnunol,2003,171(10):4 969-4 973.

二级参考文献8

  • 1Inglesby TV,O'Toole T,Henderson DA,et al.Anthrax as a biological weapon,2002:updated recommendations for management[J].JAMA,2002,287 (17):2 236-2 252.
  • 2Chabot DJ,Scorpio A,Tobery SA,et al.Anthrax capsule vaccine protects against experimental infection[J].Vaccine,2004,23 (1):43-47.
  • 3Oggioni MR,Ciabattini A,Cuppone AM,et al.Bacillus spores for vaccine delivery[J].Vaccine,2003,21 (Suppl2):S96-S101.
  • 4Brossier F,Levy M,Mock M.Anthrax spores make an essential contribution to vaccine efficacy[J].Infect Immun,2002,70 (2):661-664.
  • 5Demicheli V,Rivetti D,Deeks JJ,et al.The effectiveness and safety of vaccines against human anthrax:a systematic review[J].Vaccine,1998,16 (9/10):880-884.
  • 6Puziss M,Howard MB.Studies on immunity in anthrax.Ⅺ.Control of cellular permeability by bicarbonate ion in relation to protective antigen elaboration[J].J Bacteriol,1963,85:237-243.
  • 7庄汉澜 胡娟 梁厚勤.炭疽保护性抗原的制备Ⅰ,影响抗原形成条件的研究[J].军事医学科学院院刊,1979,8(4):463-472.
  • 8Little SF,Knudson GB.Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig[J].Infect Immun,1986,52 (2):509-512.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部